Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunogenicity”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00001053
What this trial is testing

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT03929172
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects

Who this might be right for
Papillomavirus Infections
2A Pharma AB 20
Very early researchStudy completedNCT03277456
What this trial is testing

Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1

Who this might be right for
Human Volunteers
Barinthus Biotherapeutics 6
Early research (Phase 1)Looking for participantsNCT07358156
What this trial is testing

Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.

Who this might be right for
Atopic Dermatitis
Chong Kun Dang Pharmaceutical 519
Testing effectiveness (Phase 2)Study completedNCT00689351
What this trial is testing

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea

Who this might be right for
Pneumococcal Vaccine
Wyeth is now a wholly owned subsidiary of Pfizer 180
Testing effectiveness (Phase 2)UnknownNCT05329051
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Sinocelltech Ltd. 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07675629
What this trial is testing

Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults

Who this might be right for
HIV Prevention
Worcester HIV Vaccine 126
Testing effectiveness (Phase 2)Study completedNCT00857493
What this trial is testing

Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects

Who this might be right for
Smallpox
Bavarian Nordic 120
Testing effectiveness (Phase 2)Study completedNCT03203421
What this trial is testing

A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2

Who this might be right for
Malaria
University of Oxford 18
Post-approval studies (Phase 4)Study completedNCT02563093
What this trial is testing

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 208
Testing effectiveness (Phase 2)Study completedNCT00258934
What this trial is testing

Immunogenicity Study of the Influenza Vaccine in Adults

Who this might be right for
Orthomyxoviridae InfectionsInfluenza
Sanofi Pasteur, a Sanofi Company 978
Post-approval studies (Phase 4)Study completedNCT02686398
What this trial is testing

Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis

Who this might be right for
InfluenzaEnd Stage Renal FailureChronic Kidney Disease
Korea University Guro Hospital 174
Large-scale testing (Phase 3)Study completedNCT01033877
What this trial is testing

Immunogenicity and Safety of Tetanus, Diphtheria and Mono Component Acellular Pertussis (TdaP) Vaccine in Comparison to Tetanus and Diphtheria (Td) Vaccine When Given as Booster Vaccinations to Adults

Who this might be right for
Healthy
Statens Serum Institut 802
Testing effectiveness (Phase 2)UnknownNCT04170595
What this trial is testing

Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection

Who this might be right for
HER2-positive Breast Cancer
Genor Biopharma Co., Ltd. 132
Post-approval studies (Phase 4)Study completedNCT01691339
What this trial is testing

Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 200
Early research (Phase 1)Temporarily pausedNCT06905275
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 25
Early research (Phase 1)UnknownNCT05007275
What this trial is testing

Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers

Who this might be right for
Covid19SARS-CoV-2 Infection
Imperial College London 28
Not applicableStudy completedNCT05121662
What this trial is testing

COVID-19 Vaccine Biomarker Study in Multiple Sclerosis

Who this might be right for
Multiple SclerosisCOVID-19
Columbia University 154
Early research (Phase 1)Study completedNCT06523088
What this trial is testing

PN20 in Healthy Adult Volunteers

Who this might be right for
Chemotherapy-induced ThrombocytopeniaImmune Thrombocytopenic Purpura
Chongqing Peg-Bio Biopharm Co., Ltd. 27
Early research (Phase 1)Study completedNCT01509846
What this trial is testing

Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults

Who this might be right for
Shigellosis
PATH 82
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation